Mylan Faces Fight To Bar Generic Sleep Aid As Launch Nears
Neurim Pharmaceuticals urged an appeals court Thursday to grant an injunction blocking Mylan from selling a generic version of Neurim's patented insomnia treatment, with the drug giant poised to launch its...To view the full article, register now.
Already a subscriber? Click here to view full article